QuVa Pharma recalls

QuVa Pharma has 38 recalls on record with the FDA and USDA, the earliest in 2016 and the latest reported on 15 Jul 2026. 5 are still ongoing. 2 were reported in the last 12 months. The most frequent reason is particulate matter.

Total recalls38since 2016
Last 12 months2reported
Class I25% of total
Ongoing5latest 15 Jul 2026

Recalls per month, last 24 months

click a bar for that month

Severity split

Class I 2 5%Class II 33 87%Class III 3 8%

By year

Ongoing quva pharma recalls

5 active

All quva pharma recalls, newest first

38 total
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIMethohexital Sodium, 100 mg/ (10 mg/mL), Total Volume recalledQuVa PharmaPotency & AssayNationwide
DrugCLASS IIR.E.C.K. (Ropivacaine HCl, EPINEPHrine, CloNIDine HCl recalledQuVa PharmaParticulate MatterNationwide
DrugCLASS IIfentaNYL Citrate PF 200 mcg recalled by QuVa PharmaQuVa PharmaSterilityNationwide
DrugCLASS IIfentaNYL Citrate PF 200 mcg recalled by QuVa PharmaQuVa PharmaSterilityNationwide
DrugCLASS IIfentaNYL Citrate PF 200 mcg recalled by QuVa PharmaQuVa PharmaSterilityNationwide
DrugCLASS IIIoxyTOCIN/mL) added to 0.9% Sodium Chloride, Injection recalledQuVa PharmaPackaging DefectsNationwide
DrugCLASS IIIR.E.C.K. (Ropivacaine, Epinephrine, Clonidine, Ketorolac) recalledQuVa PharmaParticulate MatterNationwide
DrugCLASS IIoxyTOCIN/mL) added to 0.9% Sodium Chloride Injection for IV Use recalledQuVa PharmaPotency & AssayNationwide
DrugCLASS IIfentaNYL 500 mcg/ (2 mcg/mL) BUPivacaine HCl recalled by QuVa PharmaQuVa PharmaParticulate MatterNationwide
DrugCLASS IIfentaNYL 1500 mcg/ (50 mcg/mL) PCA Vial Preservative Free recalledQuVa PharmaParticulate MatterNationwide
DrugCLASS IIfentaNYL 500 mcg/ (2 mcg/mL) Bupivacaine HCl 0.1% 250 mg recalledQuVa PharmaParticulate MatterNationwide
DrugCLASS IIfentaNYL 200 mcg/ (2 mcg/mL) 0.125% Bupivacaine HCl 125 mg recalledQuVa PharmaParticulate MatterNationwide
DrugCLASS IIfentaNYL 400 mcg/ (2 mcg/mL) ROPivacaine HCl 0.2% 400 mg recalledQuVa PharmaParticulate MatterNationwide
DrugCLASS IIfentaNYL 500 mcg/ (2 mcg/mL) ROPivacaine HCl 0.2% 500 mg recalledQuVa PharmaParticulate MatterNationwide
DrugCLASS IIfentaNYL 1500 mcg/ (50 mcg/mL) in Syringe Preservative Free recalledQuVa PharmaParticulate MatterNationwide
DrugCLASS IIfentaNYL 1000 mcg/ (10 mcg/mL) recalled by QuVa PharmaQuVa PharmaParticulate MatterNationwide
DrugCLASS IIfentaNYL 100 mcg/ (50 mcg/mL) Preservative Free, Rx recalledQuVa PharmaParticulate MatterNationwide
DrugCLASS IIfentaNYL 200 mcg/ (2 mcg/mL) BUPivacaine HCl 0.1% 100 mg recalledQuVa PharmaParticulate MatterNationwide
DrugCLASS IIfentaNYL 2500 mcg/ (10 mcg/mL) recalled by QuVa PharmaQuVa PharmaParticulate MatterNationwide
DrugCLASS IIfentaNYL 250 mcg/ (50 mcg/mL) Syringe, Preservative Free recalledQuVa PharmaParticulate MatterNationwide
DrugCLASS IIfentaNYL 1000 mcg/ (50 mcg/mL) in Syringe Preservative Free recalledQuVa PharmaParticulate MatterNationwide
DrugCLASS IIfentaNYL 200 mcg/ (2 mcg/mL) BUPivacaine HCl 0.125% 125 mg recalledQuVa PharmaParticulate MatterNationwide
DrugCLASS IIfentaNYL 1000 mcg/ (10 mcg/mL) recalled by QuVa PharmaQuVa PharmaParticulate MatterNationwide
DrugCLASS IIfentaNYL 500 mcg/ (2 mcg/mL) 0.125% BUPivacaine HCl recalledQuVa PharmaParticulate MatterNationwide
DrugCLASS IIfentaNYL 400 mcg/ (2 mcg/mL) 0.1% ROPivacaine HCl 200 mg recalledQuVa PharmaParticulate MatterNationwide
DrugCLASS IIfentaNYL 200 mcg/ (2 mcg/mL) BUPivacaine HCl 0.1% 100 mg recalledQuVa PharmaParticulate MatterNationwide
DrugCLASS IIfentaNYL 400 mcg/ (2 mcg/mL) ROPivacaine HCl 0.1% 200 mg recalledQuVa PharmaParticulate MatterNationwide
DrugCLASS IIfentaNYL 550 mcg/ (10 mcg/mL) recalled by QuVa PharmaQuVa PharmaParticulate MatterNationwide
DrugCLASS IIfentaNYL 800 mcg/ (4 mcg/mL) BUPivacaine HCl recalled by QuVa PharmaQuVa PharmaParticulate MatterNationwide
DrugCLASS IIfentaNYL 200 mcg/ (2 mcg/mL) ROPivacaine HCl 0.2% 200 mg recalledQuVa PharmaParticulate MatterNationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.